Compare
Mounjaro vs. Zepbound

Mounjaro (tirzepatide) is a prescription injection used to improve blood sugar control in people 10 years and older with Type 2 diabetes. It works best when you also follow a nutritious diet and exercise regularly. Mounjaro (tirzepatide) belongs to the drug class called GIP and GLP-1 agonists. The dosage is convenient because it's injected under the skin once a week. Some common side effects of Mounjaro (tirzepatide) include nausea and diarrhea. It can also lower your appetite, which might lead to some weight loss.

• Type 2 diabetes in adults and children 10 years of age and older

• Nausea (12-18%)
• Diarrhea (12-17%)
• Low appetite (5-11%)
• Vomiting (5-9%)
• Indigestion (5-8%)
• Constipation (6-7%)
• Stomach pain (5-6%)

• Risk of thyroid cancer
• Inflammation of the pancreas (pancreatitis)
• Low blood sugar (hypoglycemia) when used with other diabetes medications
• Allergic reactions
• Stomach side effects
• Kidney damage due to dehydration
• Eye problems in people with diabetic retinopathy
• Gallbladder problems
• Lung problems during general anesthesia or deep sedation
• Don't share Mounjaro KwikPens with anyone

Zepbound (tirzepatide) is an injectable medication that's used along with diet and exercise. It helps with weight loss in adults who meet criteria for weight management therapy. It's also approved to treat moderate-to-severe sleep apnea. This medication belongs to the drug class called GIP and GLP-1 agonists. The dosage is 1 injection under the skin once a week. Common side effects include nausea, diarrhea, and injection site reactions. Zepbound (tirzepatide) is only available as a brand-name medication.

In addition to a balanced diet and exercise plan:

• Weight loss and long-term weight management in adults considered obese or overweight with at least one weight-related condition (e.g., high blood pressure, Type 2 diabetes)
• Moderate-to-severe obstructive sleep apnea (OSA) in adults considered obese

• Nausea (25-29%)
• Diarrhea (19-23%)
• Constipation (11-17%)
• Vomiting (8-13%)
• Stomach pain (9-10%)
• Indigestion (9-10%)

• Risk of thyroid cancer
• Stomach problems
• Kidney damage
• Gallbladder problems
• Inflammation of the pancreas (pancreatitis)
• Allergic reactions
• Low blood sugar (hypoglycemia)
• Eye problems in people with Type 2 diabetes (diabetic retinopathy)
• Lung problems during general anesthesia or deep sedation
• Don't share Zepound KwikPens with anyone